Press Releases
May 5, 2009
Evoke Pharma, Inc. Initiates Phase 2B Metoclopramide Intranasal Trial (Mint) In Patients With Diabetic Gastroparesis
June 15, 2008
Evoke Pharma, Inc. Announces Successful Pharmacokinetic Trial Results for EVK-001
